Correlates of adherence to respiratory drugs in COPD patients

Primary Care Respiratory Journal

Volumn 19, Issue 2, 2010, Pages 148-154

  Laforest, Laurent ^a   Denis, Francois ^b   van Ganse, Eric ^a   Ritleng, Cecile ^a   Saussier, Christel ^c   Passante, Nadine ^a   Devouassoux, Gilles ^d   Chatté, Gerard ^e   Freymond, Nathalie ^d   Pacheco, Yves ^d  

^a HOSPICES CIVILS DE LYON   (France)

^b BOEHRINGER INGELHEIM   (France)

^c AFSSAPS   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

^e Lung specialist   (France)

Author keywords

Adherence; Chronic obstructive pulmonary disease; Interruptions; Omission; Respiratory therapy; Supervision; Treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FENSPIRIDE; LONG ACTING DRUG; OXYGEN; RESPIRATORY TRACT AGENT; SHORT ACTING DRUG;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; SELF REPORT;

ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYSTEM AGENTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING;

EID: 77954946292     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2010.00004     Document Type: Article

References (26)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Bethesda, MD: National Institutes of Health (NIH publication no. 2701); Updated 2005.
2. Hurd S. The Impact of COPD on Lung Health Worldwide epidemiology and incidence. Chest 2000;117(2 Suppl):1S-4S. http://dx.doi.org/10.1378/chest.117.2_suppl.1S
3. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000;55(12):1000-06.http://dx.doi.org/10.1136/thorax.55.12.1000
4. Piperno D. The burden of COPD in France: results from the Confronting COPD survey. Respir Med 2003;97(Suppl C):S33-42. http://dx.doi.org/10.1016/S0954-6111(03)80023-9
5. Vermeire P. The burden of chronic obstructive pulmonary disease. Respir Med 2002;96(Suppl C):S3-10. http://dx.doi.org/10.1016/S0954-6111(02)80028-2
6. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006;27(1):188-207. http://dx.doi.org/10.1183/09031936.06.00024505
7. van Grunsven PM, van Schayck CP, van Deuveren M, van Herwaarden CL, Akkermans RP, van Weel C. Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma 2000;37(3):225-34. http://dx.doi.org/10.3109/02770900009055445
8. Earnest MA. Explaining adherence to supplemental oxygen therapy: the patient's perspective. J Gen Intern Med 2002;17(10):749-55. http://dx.doi.org/10.1046/j.1525-1497.2002.20218.x
9. Corden ZM, Bosley CM, Rees PJ, Cochrane GM. Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. Chest 1997;112(5):1278-82. http://dx.doi.org/10.1378/chest.112.5.1278
10. Turner J, Wright E, Mendella L, Anthonisen N. Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing. Chest 1995;108(2):394-400. http://dx.doi.org/10.1378/chest.108.2.394
11. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008;63(9):831-8. http://dx.doi.org/10.1136/thx.2007.086041
12. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for non compliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160(14):2101-07. http://dx.doi.org/10.1001/archinte.160.14.2101
13. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008;336(7653):1114-17.
14. Rand CS, Nides M, Cowles MK, Wise RA, Connett J. Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med 1995;152(2):580-8.
15. George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 2005;128(5):3198-204. http://dx.doi.org/10.1378/chest.128.5.3198
16. Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL. Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. Am J Respir Crit Care Med 1998;157(6Pt 1):1810-17.
17. Krigsman K, Moen J, Nilsson JL, Ring L Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther 2007;32(6):603-11. http://dx.doi.org/10.1111/j.1365-2710.2007.00866.x
18. Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC. Medication adherence patterns in chronic obstructive pulmonary disease. Chest 1991;99(4):837-41. http://dx.doi.org/10.1378/chest.99.4.837
19. Camp PG, Goring SM. Gender and the diagnosis, management, and surveillance of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007;4(8):686-91. http://dx.doi.org/10.1513/pats.200706-081SD
20. Lau HS, Beuning KS, Postma-Lim E, Klein-Beernink L, de Boer A, Porsius AJ. Non-compliance in elderly people: evaluation of risk factors by longitudinal data analysis. Pharm World Sci 1996;18(2):63-8. http://dx.doi.org/10.1007/BF00579707
21. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23(8):1296-310. http://dx.doi.org/10.1016/S0149-2918(01)80109-0
22. George J, Kong DC, Stewart K. Adherence to disease management programs in patients with COPD. Int J Chron Obstruct Pulmon Dis 2007;2(3):253-62.
23. Van Ganse E, Mork AC, Osman LM, Vermeire P, Laforest L, Marrel A, Stahl E. Factors affecting adherence to asthma treatment: patient and physician perspectives. Prim Care Resp J 2003;12(2):46-51.
24. De Smet BD, Erickson SR, Kirking DM. Self-reported adherence in patients with asthma. Ann Pharmacother 2006;40(3):414-20. http://dx.doi.org/10.1345/aph.1G475
25. Garcia-Aymerich J, Hernandez C, Alonso A, et al. Effects of an integrated care intervention on risk factors of COPD readmission. Respir Med 2007;101(7):1462-9. http://dx.doi.org/10.1016/j.rmed.2007.01.012
26. Casas A, Troosters T, Garcia-Aymerich J, et al.; members of the CHRONIC Project. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J 2006;28(1):123-30. http://dx.doi.org/10.1183/09031936.06.00063205